Anti-cancer activity of phenyl-1,3,5-heptatriyne  in human liver cancer

Uzma Faridi

doi:10.56782/pps.275

Published : 2024-12-23

Vol. 22 No. 4 (2024)

Anti-cancer activity of phenyl-1,3,5-heptatriyne in human liver cancer

Uzma Faridi

DOI: https://doi.org/10.56782/pps.275

Abstract

Bidens pilosa, commonly known as Ottrancedi, is a medicinal plant from the ancient period. It contains polyacetylenes, flavonoids, terpenoids, phenylpropanoids, which are well known molecules present in high concentration in medicinal plants with many antibacterial, antifungal and anticancer properties. To study the detailed mode of action of phenyl-1,3,5-heptatriyne which showed promising results on human liver cancer cell line HepG-2, we performed many assays like DNA fragmentation assay, Caspase-3 assay, Cell cycle analysis and fluorescent microscopic studies. During over studies we found that the molecule causes apoptosis in cancer cells lines by expressing high amount of Caspase-3 enzyme and it arrests the cells in G2/M phase. As it is already reported that the infusion of B. pilosa L. is non-toxic for single and repeated dose also for dermal structures so the molecule phenyl-1,3,5-heptatriyne can be a good candidate for a anticancer drug in future.

Keywords:

liver cancer, phenyl-1,3,5-heptatriyne, apoptosis, anticancer

Similar Articles

Teresa Żołek, Aleksandra Trzeciak, THE MECHANISM OF ACTION OF INDOLE-3-CARBINOL AND 3,3´-DIINDOLYLMETHANE IN CANCER CHEMOPREVENTION , Prospects in Pharmaceutical Sciences: Vol. 15 No. 2 (2017)
Agnieszka Lembas, Andrzej Załęski, Tomasz Mikuła, Joanna Jabłońska, Szymon Barczak, Barbara Badura, Alicja Wiercińska-Drapało, Differences in the course of hepatocellular carcinoma depending on the DAA treatment , Prospects in Pharmaceutical Sciences: Vol. 22 No. 3 (2024)
Aneta Affek, Maria Niemyjska, Martyna Wełpa, INDAZOLE DERIVATIVES AS ANTICANCER AGENTS , Prospects in Pharmaceutical Sciences: Vol. 15 No. 1 (2017)
Agata Pisula, Agnieszka Sienicka, Agnieszka Dobrowolska-Redo, Joanna Kacperczyk-Bartnik, Ewa Romejko-Wolniewicz, PARP inhibitors in ovarian cancer therapy , Prospects in Pharmaceutical Sciences: Vol. 22 No. 2 (2024)
Ewelina Flegiel, Magdalena Piotrowska, Magdalena Ptasznik, Aleksandra Baran, Justyna Lenart, Miłosz Podrażka, Joanna Mazurek, Hubert Stachowicz, Weronika Bartos, Monika Adamczyk, Review of the effects of sodium butyrate on obesity, inflammatory bowel disease, pregnancy and colorectal cancer , Prospects in Pharmaceutical Sciences: Vol. 22 No. 4 (2024)
Paweł Żero, Maria Niemyjska, Magdalena Rasztawicka, Dorota Maciejewska, BREAST CANCER DISEASE AND NEW COMPOUNDS WITH ANTICANCER ACTIVITY , Prospects in Pharmaceutical Sciences: Vol. 3 No. 2 (2005)
Jadwiga Piwowarska, Jolanta Felczak, Jacek Łukaszkiewicz, CONCENTRATION OF MALONDIALDEHYDE IN BLOOD AS AN INDICATOR IN LIVER TRANSPLANTATION , Prospects in Pharmaceutical Sciences: Vol. 14 No. 6 (2016)
Magdalena Bamburowicz-Klimkowska, Mirosław M. Szutowski, STRATEGIES TO COMBAT MULTIDRUG RESISTANCE OF CANCER , Prospects in Pharmaceutical Sciences: Vol. 10 No. 1 (2012)
Mateusz Żaczko, Tomasz Lorenc, Wioletta Olejarz, Grażyna Nowicka, PERSPECTIVES OF THERAPEUTIC USE OF EXOSOMES IN THE MOST COMMON CANCERS , Prospects in Pharmaceutical Sciences: Vol. 17 No. 6 (2019)
Kinga Byk, Filip Charuk, Ewa Olędzka, Marcin Sobczak, Monika Zielińska-Pisklak, CLINICAL APPLICATIONS OF PACLITAXEL IN CANCER THERAPY , Prospects in Pharmaceutical Sciences: Vol. 19 No. 2 (2021)

1 2 3 4 5 > >>

You may also start an advanced similarity search for this article.

Details

References

Statistics

Authors

Download files

PDF

Citation rules

Faridi, U. (2024). Anti-cancer activity of phenyl-1,3,5-heptatriyne in human liver cancer. Prospects in Pharmaceutical Sciences, 22(4), 131–134. https://doi.org/10.56782/pps.275

Altmetric indicators

Cited by / Share

Licence

This work is licensed under a Creative Commons Attribution 4.0 International License.

References

1. Kumari, P.; Misra, K.; Sisodia, B.S.; Faridi, U.; Srivastava, S.; Luqman, S.; Darokar, M.P.; Negi, A.S.; Gupta, M.M.; Singh, S.C.; Kumar, J.K. A promising anticancer and antimalarial component from the leaves of Bidens pilosa. Planta Med. 2009, 75, 59-61. DOI: 10.1055/s-0028-1088362

2. Chiang, Y.M.; Chang, C.L.T.; Chang, S.L.; Yang, W.C.; Shyur, L.F. Cytopiloyne, a novel polyacetylenic glucoside from Bidens pilosa, functions as a T helper cell modulator. J. Ethnopharmacol. 2007, 110, 532-538. DOI: 10.1016/j.jep.2006.10.007

3. Chang, S.L.; Chang, C.L.T.; Chiang, Y.M.; Hsieh, R.H.; Tzeng, C.R.; Wu, T.K.; Sytwu, H.K.; Shyur, L.F.; Yang, W.C. Polyacetylenic compounds and butanol fraction from Bidens pilosa can modulate the differentiation of helper T cells and prevent autoimmune diabetes in non-obese diabetic mice. Planta Med. 2004, 70, 1045-1051. DOI: 10.1055/s-2004-832645

4. Cai, J.; Shi, S.Y.; Cheng, F.; Wei, M.; Zou, K.; Yu, X.Q.; Chen, J.F. Polyacetylene isomers isolated from Bidens pilosa L. suppress the metastasis of gastric cancer cells by inhibiting Wnt/β-Catenin and Hippo/YAP signaling pathways. Molecules 2023, 28, Art. No: 1837. DOI: 10.3390/molecules28041837

5. Cárdenas, M.B.; Álvarez, C.S.; Morgado, E.B.; Gutiérrez, M.G.; Monteagudo, G.L.; Suarez, O.S. Toxicological evaluation of an infusion of Bidens pilosa. Pharmacol. Online 2006, 3, 428-434.

6. Steenkamp, V.; Gouws, M.C. Cytotoxicity of six South African medicinal plant extracts used in the treatment of cancer. S. Afr. J. Bot. 2006, 72, 630-633. DOI: 10.1186/1472-6882-11-14

7. Carmichael, J.; DeGraff, W.G.; Gazdar, A.F.; Minna, J.D.; Mitchell, J.B. Evaluation of a tetrazolium-based semiautomated colorimetric assay: assessment of chemosensitivity testing. Cancer Res. 1987, 47, 936-942.

8. Herrmann, M.; Lorenz, H.M.; Voll, R.E.A.; Grünke, M.; Woith, W.; Kalden, J.R. A rapid and simple method for the isolation of apoptotic DNA fragments. Nucleic Acids Res. 1994, 22, Art. No: 5506. DOI: 10.1093/nar/22.24.5506

9. Boquest, A.C.; Day, B.N.; Prather, R.S. Flow cytometric cell cycle analysis of cultured porcine fetal fibroblast cells. Biol. Reprod. 1999, 60, 1013-1019. DOI: 10.1095/biolreprod60.4.1013

10. Lu, K.H.; Lue, K.H.; Liao, H.H.; Lin, K.L.; Chung, J.G. Induction of caspase-3-dependent apoptosis in human leukemia HL-60 cells by paclitaxel. Clin. Chim. Acta 2005, 357, 65-73. DOI: 10.1016/j.cccn.2005.02.003

11. Jurisicova, A.; Varmuza, S.; Casper, R.F. Programmed cell death and human embryo fragmentation. MHR: Basic Sci. Reprod. Med. 1996, 2, 93-98. DOI: 10.1093/molehr/2.2.93

12. Kim, H.Y.; Akbar, M.; Lau, A.; Edsall, L. Inhibition of neuronal apoptosis by docosahexaenoic acid (22:6n-3): role of phosphatidylserine in antiapoptotic effect. J. Biol. Chem. 2000, 275, 35215-35223. DOI: 10.1074/jbc.M004446200

13. Li, H.; Wang, L.J.; Qiu, G.F.; Yu, J.Q.; Liang, S.C.; Hu, X.M. Apoptosis of HeLa cells induced by extract from Cremanthodium humile. Food Chem. Toxicol. 2007, 45, 2040-2046. DOI: 10.1016/j.fct.2007.05.001

14. Weng, S.L.; Taylor, S.L.; Morshedi, M.; Schuffner, A.; Duran, E.H.; Beebe, S.; Oehninger, S. Caspase activity and apoptotic markers in ejaculated human sperm. Mol. Hum. Reprod. 2002, 8, 984-991. DOI: 10.1093/molehr/8.11.984

15. Arruebo, M.; Vilaboa, N.; Sáez-Gutierrez, B.; Lambea, J.; Tres, A.; Valladares, M.; González-Fernández, Á. Assessment of the evolution of cancer treatment therapies. Cancers 2011, 3, 3279-3330. DOI: 10.3390/cancers3033279

16. Sakahira, H.; Enari, M.; Nagata, S. Cleavage of CAD inhibitor in CAD activation and DNA degradation during apoptosis. Nature 1998, 391, 96-99. DOI: 10.1038/34214

17. Janicke, R.U.; Sprengart, M.L.; Wati, M.R.; Porter, A.G. Caspase-3 is required for DNA fragmentation and morphological changes associated with apoptosis. J. Biol. Chem. 1998, 273, 9357-9360.

18. Vermeulen, K.; Van Bockstaele, D.R.; Berneman, Z.N. The cell cycle: a review of regulation, deregulation and therapeutic targets in cancer. Cell Prolif. 2003, 36, 131-149. DOI: 10.1046/j.1365-2184.2003.00266.x

19. Shapiro, G.I.; Harper, J.W. Anticancer drug targets: cell cycle and checkpoint control. J. Clin. Invest. 1999, 104, 1645-1653, DOI: 10.1172/JCI9054